FDA.reportPublic FDA data

axicabtagene ciloleucel 200,000,000 CELLS in 68 mL Injection

RxCUI
1987402
RxNorm name
axicabtagene ciloleucel 200,000,000 CELLS in 68 mL Injection
Display name
axicabtagene ciloleucel 200,000,000 CELLS in 68 mL Injection
Full name
axicabtagene ciloleucel 200,000,000 CELLS in 68 mL Injection
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:10

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125643Yescartaaxicabtagene ciloleucel351(a)Rx2026-06-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
YESCARTAAXICABTAGENE CILOLEUCELKite Pharma, Inc.9b70606e-b99c-4272-a0f1-b5523cce0c592026-06-15Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 1987402

DailyMed RxNorm Mappings#

Set ID, RxNorm string, TTY table
Set IDRxNorm stringTTYSPL versionLabelEffective
9b70606e-b99c-4272-a0f1-b5523cce0c59axicabtagene ciloleucel 200,000,000 CELLS in 68 mL InjectionPSN21These highlights do not include all the information needed to use YESCARTA safely and effectively. See full prescribing information for YESCARTA. YESCARTA ® (axicabtagene ciloleucel) suspension for intravenous infusion Initial U.S. Approval: 201720260212
9b70606e-b99c-4272-a0f1-b5523cce0c59axicabtagene ciloleucel 200,000,000 CELLS per 68 ML InjectionSY21These highlights do not include all the information needed to use YESCARTA safely and effectively. See full prescribing information for YESCARTA. YESCARTA ® (axicabtagene ciloleucel) suspension for intravenous infusion Initial U.S. Approval: 201720260212
9b70606e-b99c-4272-a0f1-b5523cce0c5968 ML axicabtagene ciloleucel 2940000 CELLS/ML InjectionSCD21These highlights do not include all the information needed to use YESCARTA safely and effectively. See full prescribing information for YESCARTA. YESCARTA ® (axicabtagene ciloleucel) suspension for intravenous infusion Initial U.S. Approval: 201720260212